Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026)
Insight Molecular Diagnostics (IMDX) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 266.00 |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -211.00 |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 399.00 |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 28.00 |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -317.00 |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 4,440.00 |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 3,000.00 |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 135.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | -2.00 |
| 10 | Insight Molecular Diagnostics | 172.94 Mn | 144.01 Mn | 15,000.00 | -3.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.71 Mn |
| Dec 31, 2025 | -178,514.00 |
| Sep 30, 2025 | -23,041.00 |
| Jun 30, 2025 | -105,189.00 |
| Mar 31, 2025 | -3,894.00 |
| Dec 31, 2024 | -128,454.00 |
| Sep 30, 2024 | -632,365.00 |
| Jun 30, 2024 | -438,992.00 |
| Mar 31, 2024 | -416,531.00 |
| Dec 31, 2023 | -380,711.00 |
| Sep 30, 2023 | -29,043.00 |
| Jun 30, 2023 | 456,945.00 |
| Mar 31, 2023 | 5.72 Mn |